Progress of gut-kidney axis in the pathogenesis of crescentic glomerulonephritis

doi:10.16352/j.issn.1001-6325.2022.04.016

Abstract

Abstract: Crescent glomerulonephritis (CreGN) is the most dangerous glomerulonephritis and always leads to end stage renal disease (ESRD). The immunological mechanism plays an important role in its pathogenesis and prognosis. Recently, the role of the gut and intestinal microbiota in a variety of kidney diseases including CreGN has been disclosed. The “gut-kidney axis” will directly affect the immune response in the kidney and subsequent pathophysiology through the intestinal microbiota and gut-derived immune cells.

Key words: gut-kidney axis, intestinal microbiota, crescentic glomerulonephritis, intestinal mucosal immunity, molecular simulation

CLC Number:

YIN Huan-huan, SHI Xiao-xiao, CHEN Li-meng. Progress of gut-kidney axis in the pathogenesis of crescentic glomerulonephritis[J]. Basic & Clinical Medicine, 2022, 42(4): 656-660.

References

[1] Krebs CF, Paust HJ, Krohn S, et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney[J]. Immunity, 2016, 45: 1078-1092.
[2] Tao S, Li L, Li L, et al. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition[J]. Acta Diabetol, 2019, 56: 581-592.
[3] Marques C, Carvelli J, Biard L, et al. Prognostic factors in anti-glomerular basement membrane disease: a multicenter study of 119 patients[J]. Front Immunol, 2019,10:1665. doi: 10.3389/fimmu.2019.01665.
[4] Hu SY, Jia XY, Gu QH, et al. T cell responses to peptides of Goodpasture autoantigen in patients with anti-glomerular basement membrane disease[J]. Nephrology, 2018, 23: 345-350.
[5] Huynh M, Eggenhuizen PJ, Olson GL, et al. HLA-DR15-specific inhibition attenuates autoreactivity to the Goodpasture antigen[J]. J Autoimmun, 2019, 103: 102276. doi: 10.1016/j.jaut.2019.05.004.
[6] Mayer U, Schmitz J, Bräsen JH, et al. Crescentic glomerulonephritis in children[J]. Pediatr Nephrol, 2020, 35: 829-842.
[7] Wang Y, Zhang S, Zhang N, et al. Reduced activated regulatory T cells and imbalance of Th17/activated Treg cells marks renal involvement in ANCA-associated vasculitis[J]. Mol Immunol, 2020, 118: 19-29.
[8] Arrazuria R, Pérez V, Molina E, et al. Diet induced changes in the microbiota and cell composition of rabbit gut associated lymphoid tissue (GALT)[J]. Sci Rep, 2018, 8: 14103. doi: 10.1038/s41598-018-32484-1.
[9] Lee JR, Magruder M, Zhang L, et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients[J]. Am J Transplant, 2019, 19: 488-500.
[10] Ticinesi A, Milani C, Guerra A, et al. Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers[J]. Gut, 2018, 67: 2097-2106.
[11] Feng YL, Cao G, Chen DQ, et al. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease[J]. Cell Mol Life Sci, 2019, 76: 4961-4978.
[12] Li F, Wang M, Wang J, et al. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease[J]. Front Cell Infect Microbiol, 2019, 9: 206. doi: 10.3389/fcimb.2019.00206.
[13] Dolff S, Witzke O, Wilde B. Th17 cells in renal inflammation and autoimmunity[J]. Autoimmun Rev, 2019, 18: 129-136.
[14] Diefenhardt P, Nosko A, Kluger MA, et al. IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN[J]. J Am Soc Nephrol, 2018, 29: 1825-1837.
[15] Wang Y, Yin Y, Chen X, et al. Induction of intestinal Th17 cells by flagellins from segmented filamentous bacteria[J]. Front Immunol, 2019, 10: 2750. doi: 10.3389/fimmu.2019.02750.
[16] Welsh-Bacic D, Lindenmeyer M, Cohen CD, et al. Expression of the chemokine receptor CCR6 in human renal inflammation[J]. Nephrol Dial Transplant, 2011, 26: 1211-1220.
[17] Arends J, Wu J, Borillo J, et al. T cell epitope mimicry in antiglomerular basement membrane disease[J]. J Immunol, 2006, 176: 1252-1258.
[18] Li JN, Jia X, Wang Y, et al. Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides[J]. PLoS One, 2017, 12: e0174553. doi: 10.1371/journal.pone.0174553.
[19] Li N, Zhu B, Zhu Q, et al. Serum lysosomal-associated membrane protein-2 levels are increased in small and medium-vessel vasculitis, especially in polyarteritis nodosa[J]. Clin Exp Rheumatol, 2019, 37(Suppl),117: 79-85.
[20] Sanchez B, Hevia A, Gonzalez S, et al. Interaction of intestinal microorganisms with the human host in the framework of autoimmune diseases[J]. Front Immunol, 2015, 6: 594. doi: 10.3389/fimmu.2015.00594.
[21] Hatemi I, Hatemi G, Celik AF. Systemic vasculitis and the gut[J]. Curr Opin Rheumatol, 2017, 29: 33-38.
[22] Vojdani A, Vojdani E, Herbert M, et al. Correlation between antibodies to bacterial lipopolysaccharides and barrier proteins in sera positive for ASCA and ANCA[J]. Int J Mol Sci, 2020, 21:1381. doi: 10.3390/ijms21041381.
[23] Kronbichler A, Kerschbaum J, Mayer G. The influence and role of microbial factors in autoimmune kidney diseases: a systematic review[J]. J Immunol Res, 2015, 2015: 858027. doi: 10.1155/2015/858027.
[24] Elaziz MMA, Fayed A. Patterns of renal involvement in a cohort of patients with inflammatory bowel disease in Egypt[J]. Acta Gastroenterol Belg, 2018, 81: 381-385.
[25] 张静,王肖枭,周怡,等. 肠道菌群与疾病相关性的研究进展[J]. 基础医学与临床, 2020, 40: 243-247.